Melanocortin 1 receptor agonists reduce proteinuria

Journal of the American Society of Nephrology

Volumn 21, Issue 8, 2010, Pages 1290-1298

  Lindskog, Annika ^a   Ebefors, Kerstin ^a   Johansson, Martin E ^b   Stefánsson, Bergur ^a   Granqvist, Anna ^a   Arnadottir, Margret ^c   Berg, Anna Lena ^d   Nyström, Jenny ^a   Haraldsson, Börje ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MS 05; SYNAPTOPODIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEYMANN NEPHRITIS; HUMAN; KIDNEY TUBULE EPITHELIUM; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; RAT;

EID: 77955609123     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009101025     Document Type: Article

References (33)

1. Ponticelli C: Membranous nephropathy. J Nephrol 20: 268-287, 2007
2. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329: 85-89, 1993
3. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
4. Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P: A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 47: 233-240, 2006
5. Schacke H, Docke WD, Asadullah K: Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96: 23-43, 2002
6. Berg AL, Nilsson-Ehle P, Arnadottir M: Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 56: 1534-1543, 1999
7. Berg AL, Arnadottir M: ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol Dial Transplant 19: 1305-1307, 2004
8. Picardi L, Villa G, Galli F, Piazza V, Bovio G, Efficace E, Montagna G, Semeraro L, Segagni S, Salvadeo A: ACTH therapy in nephrotic syndrome induced by idiopathic membranous nephropathy. Clin Nephrol 62: 403-404, 2004
9. Rauen T, Michaelis A, Floege J, Mertens PR: Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24. Clin Nephrol 71: 637-642, 2009
10. Berg AL, Stefánsson B, Arnadottir M: A randomized, controlled study on treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy. Presented at the 2006 American Society of Nephrology Renal Week (abstract number F-PO1112), San Diego, CA, 2006
11. Eberle A: The Melanotropins, Basel, Switzerland, Karger, 1988
12. Szardenings M, Muceniece R, Mutule I, Mutulis F, Wikberg JE: New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 21: 239-243, 2000
13. Getting SJ, Christian HC, Lam CW, Gavins FN, Flower RJ, Schioth HB, Perretti M: Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: Studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170: 3323-3330, 2003
14. Salant DJ, Cybulsky AV: Experimental glomerulonephritis. Methods Enzymol 162: 421-461, 1988
15. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D: Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A 90: 3645-3649, 1993
16. Neale TJ, Ojha PP, Exner M, Poczewski H, Ruger B, Witztum JL, Davis P, Kerjaschki D: Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 94: 1577-1584, 1994
17. Lefkowitz RJ, Roth J, Pricer W, Pastan I: ACTH receptors in the adrenal: Specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci U S A 65: 745-752, 1970
18. Hogan SL, Muller KE, Jennette JC, Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25: 862-875, 1995
19. Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Dis 44: 385-401, 2004
20. Loir B, Perez Sanchez C, Ghanem G, Lozano JA, Garcia-Borron JC, Jimenez-Cervantes C: Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cell Mol Biol (Noisy-le-grand) 45: 1083-1092, 1999
21. Catania A: The melanocortin system in leukocyte biology. J Leukoc Biol 81: 383-392, 2007
22. van der Kraan M, Adan RA, Entwistle ML, Gispen WH, Burbach JP, Tatro JB: Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139: 2348-2355, 1998
23. Catania A, Gatti S, Colombo G, Lipton JM: Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56: 1-29, 2004
24. Labbe O, Desarnaud F, Eggerickx D, Vassart G, Parmentier M: Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33: 4543-4549, 1994
25. Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA: Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137: 1627-1633, 1996
26. Chhajlani V: Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38: 73-80, 1996
27. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251, 1992
28. Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G: Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int 61: 1635-1645, 2002
29. Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G: Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int 54: 353-359, 1998
30. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002
31. Bjornson A, Moses J, Ingemansson A, Haraldsson B, Sorensson J: Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am J Physiol Renal Physiol 288: F748-F756, 2005
32. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216, 1976
33. Jeansson M, Haraldsson B: Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14: 1756-1765, 2003